Exane Derivatives’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $609K | Buy |
4,267
+350
| +9% | +$50K | 0.35% | 64 |
|
|
2022
Q1 | $675K | Sell |
3,917
-14
| -0.4% | -$2.41K | 0.19% | 138 |
|
|
2021
Q4 | $998K | Buy |
3,931
+1,577
| +67% | +$401K | 0.24% | 93 |
|
|
2021
Q3 | $906K | Sell |
2,354
-139
| -6% | -$53.5K | 0.22% | 95 |
|
|
2021
Q2 | $586K | Sell |
2,493
-6,262
| -72% | -$1.47M | 0.13% | 150 |
|
|
2021
Q1 | $1.15M | Buy |
8,755
+6,227
| +246% | +$815K | 0.33% | 65 |
|
|
2020
Q4 | $264K | Buy |
2,528
+178
| +8% | +$18.6K | 0.08% | 261 |
|
|
2020
Q3 | $166K | Hold |
2,350
| – | – | 0.05% | 213 |
|
|
2020
Q2 | $151K | Buy |
+2,350
| New | +$151K | 0.04% | 220 |
|